Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Phase 3 Interventional

Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

ClinicalTrials.gov ID: NCT06605105

Public ClinicalTrials.gov record NCT06605105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Long-Term Extension Trial With Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants With Major Depressive Disorder (EXTEND)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a long- term extension of the double-blind trials APPROACH (CYB003-002) and EMBRACE (CYB003-003). Its aim is to examine the safety and long-term efficacy of CYB003 in participants with MDD.

Study identification

NCT ID
NCT06605105
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cybin IRL Limited
Industry
Enrollment
468 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 18, 2025 (Actual)
Primary completion
Jun 6, 2028 (Estimated)
Completion
Jun 6, 2028 (Estimated)
Last update posted
Sep 25, 2026

2025 – 2028

United States locations

U.S. sites
42
U.S. states
17
U.S. cities
35
Facility City State ZIP Site status
Scottsdale Research Institute Phoenix Arizona 85022 —
Behavioral Research Specialists, LLC Glendale California 91206 —
Kadima Neuropsychiatry Institute La Jolla California 92037 —
TRIP Clinic and Psychedelic Science Institute Los Angeles California 90004 —
CalNeuro Research Group Los Angeles California 90025 —
Lipov Medical Group Los Angeles California 90025 —
Excell Research, Inc Oceanside California 92056 —
Open Mind Collective / UCSF Medical Center - Mount Zion San Francisco California 94114 —
Inland Psychiatric Medical Group Inc (IPMG Research) San Juan Capistrano California 92675 —
Mountain View Clinical Research Denver Colorado 80209 —
Starlight Clinical Research Evergreen Colorado 80439 —
Research Centers of America Hollywood Florida 33024 —
Clinical Neuroscience Solutions Jacksonville Florida 32256 —
K2 Medical Research Lady Lake Florida 32159 —
Segal Trials Center for Psychedelic Research Lauderhill Florida 33319 —
Accel Research Sites - Maitland Maitland Florida 32751 —
K2 Medical Research Maitland Florida 32751 —
Clinical Neuroscience Solutions, Inc Orlando Florida 32801 —
Charter Research Orlando Florida 32803 —
Combined Research Orlando Phase I-IV Orlando Florida 32807 —
Cenexel iResearcvh Atlanta, LLC Atlanta Georgia 30030 —
Atlanta Center For Medical Research Atlanta Georgia 30331 —
CenExel iResearch Savannah Georgia 31405 —
Uptown Research Institute Chicago Illinois 60640 —
Psychiatric Medicine Associates, LLC Skokie Illinois 60076 —
Psychiatric Medicine Associates Skokie Illinois 60076 —
Sunstone Medical, PC Rockville Maryland 20850 —
Adams Clinical Boston Boston Massachusetts 02116 —
Elixia Health Springfield Massachusetts 01103 —
Adams Clinical Watertown Massachusetts 02472 —
Institute for Integrative Therapies Eden Prairie Minnesota 55347 —
Redbird Research Las Vegas Nevada 89119 —
Global Medical Institutes, Princeton Medical Institute Princeton New Jersey 08540 —
Bio Behavioral Health Toms River New Jersey 08755 —
Adams Clinical Harlem New York New York 10029 —
Adams Clinical Bronx The Bronx New York 10461 —
Neurobehavioral Clinical Research Canton Ohio 44720 —
Adams Clinical Philadelphia Philadelphia Pennsylvania 19104 —
Clinical Neuroscience Solutions, CNS Healthcare Memphis Tennessee 38119 —
Adams Clinical Dallas DeSoto Texas 75115 —
Zillan Clinical Research Houston Texas 77082 —
Cedar Clinical Research Draper Utah 84020 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06605105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06605105 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →